Empyrean Capital Partners »

Inhibrx Biosciences shares owned by Empyrean Capital Partners

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Empyrean Capital Partners from 13F filings

Historical chart of Empyrean Capital Partners investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Empyrean Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Empyrean Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8M 30k 94.75

More positions owned by Empyrean Capital Partners

ViaSat (VSAT)
Aercap Holdings Nv SHS (AER)
British Amern Tob Sponsored Adr (BTI)
Marathon Petroleum Corp (MPC)
Enova Intl (ENVA)
Brightsphere Investment Group (AAMI)
Norfolk Southern (NSC)
Union Pacific Corporation (UNP)
Newmark Group Cl A (NMRK)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Blackstone Digital Infrastru Common Stock
Apollo Global Mgmt (APO)
Capital One Financial (COF)
Churchill Cap Corp Xi Cl A Ord Shs (CCXI)
Ishares Tr Russell 2000 Etf Put Option (IWM)

View all positions for Empyrean Capital Partners

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Morgan Stanley
Sanofi
Viking Global Investors
HighTower Advisors
Bank of America Corporation
BlackRock
Schonfeld Strategic Advisors
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Woodline Partners
Capital Research Global Investors
Partner Fund Management
Sofinnova Ventures

View all funds holding Inhibrx Biosciences